Trials / Unknown
UnknownNCT02640183
EMLA Cream in Hysteroscopy Practice
Lidocaine-Prilocaine (EMLA®) Cream in Hysteroscopy Practice: A Prospective Randomized Non-blinded Controlled Study
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 184 (estimated)
- Sponsor
- Ain Shams Maternity Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate the efficacy of 5% lidocaine 25 mg-prilocaine 25 mg/g cream (EMLA®) applied to the uterine cervix for reducing pain during diagnostic hysteroscopy, using a visual analogue scale (VAS) for pain, and whether it can replace general anesthesia that may be required for some cases of office hysteroscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EMLA | |
| OTHER | Placebo |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2015-12-28
- Last updated
- 2015-12-28
Source: ClinicalTrials.gov record NCT02640183. Inclusion in this directory is not an endorsement.